Back to BALYASNY ASSET MANAGEMENT L.P. BALYASNY ASSET MANAGEMENT L.P.

SABSSABS
3 quarters

Position history for BALYASNY ASSET MANAGEMENT L.P.BALYASNY ASSET MANAGEMENT L.P.'s holdings in SAB BIOTHERAPEUTICS INC

BALYASNY ASSET MANAGEMENT L.P. holds 3.8M shares of SABS (SAB BIOTHERAPEUTICS INC), worth $14.7M as of 2026-Q2. SABS represents 0.0% of BALYASNY ASSET MANAGEMENT L.P.'s portfolio.

Current Value

$14.7M

Current Shares

3.8M

Total Value Change

+$12.9M

Total Shares Change

+3.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
3.8M
0.0%
$14.7M0.0%$3.90
0
2026-Q1
Increased
3.8M
+690.9%
$14.4M0.0%$3.89
45
2025-Q4
New
475,439
-
$1.8M0.0%$3.77
36

Other major holders of SABS: ADAGE CAPITAL PARTNERS GP, L.L.C., RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used